ABAXIS INC | 32,988 Euro | -0,107 -0,32 % | |
| WKN: 883404 ISIN: US0025671050 Ticker-Symbol: AXS | Frankfurt | 24.05.13 | 09:04 Uhr |
Branche GesundheitswesenAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 21.05. | Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference | 20 | PR Newswire | |
| UNION CITY, Calif., May 21, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Martin Mulroy, chief... Mehr lesen zu: Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference | ||||
| 08.05. | Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 23 | PR Newswire | |
| UNION CITY, Calif., May 8, 2013 /PRNewswire/ --Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson... Mehr lesen zu: Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | ||||
| 30.04. | ABAXIS INC - 8-K, Current Report | - | SEC Filings | |
| 26.04. | Abaxis's Earnings Beat Last Year's by 43% | 2 | Motley Fool | |
| 26.04. | Abaxis Shares Sinking Lower, Down 7.1% | - | SmarTrend | |
| 26.04. | ABAXIS CEO Discusses Q4 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 25.04. | Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013 | 25 | PR Newswire | |
| UNION CITY, Calif., April 25, 2013 /PRNewswire/ --Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for... Mehr lesen zu: Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013 | ||||
| 23.04. | Downgrade Alert for Abaxis | 1 | SmarTrend | |
| 17.04. | Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013 | 14 | PR Newswire | |
| UNION CITY, Calif., April 17, 2013 /PRNewswire/ --Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference... Mehr lesen zu: Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013 | ||||
| 09.04. | Ex-Abaxis Employee Will Pay $145,000 in SEC Insider Case | 1 | Bloomberg | |
| 04.04. | Abaxis Shares Up 19.9% Since SmarTrend's Buy Recommendation | 3 | SmarTrend | |
| 02.04. | Abaxis: The Winning Streak Continues | - | SmarTrend | |
| 01.04. | Abaxis Pinned at Neutral | - | Zacks | |
| 27.03. | Abaxis Has Returned 22.8% Since SmarTrend Recommendation | - | SmarTrend | |
| 20.03. | Abaxis Up 23.1% Since SmarTrend Uptrend Call | - | SmarTrend | |
| 13.03. | Abaxis Shares Up 20.4% Since SmarTrend's Buy Recommendation | 1 | SmarTrend | |
| 11.03. | Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum | 17 | PR Newswire | |
| UNION CITY, Calif., March 11, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that... Mehr lesen zu: Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum | ||||
| 25.02. | Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference | 13 | PR Newswire | |
| UNION CITY, Calif., Feb. 25, 2013 /PRNewswire/ --Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson,... Mehr lesen zu: Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference | ||||
| 25.02. | Merrill Lynch stuft Abaxis von Neutral auf Underperform ab | 36 | BörseGo | |
| Merrill Lynch stuft Abaxis von Neutral auf Underperform ab
(© BörseGo AG 2013 - Autor: Thomas Gansneder, Redakteur) Mehr lesen zu: Merrill Lynch stuft Abaxis von Neutral auf Underperform ab | ||||
| 15.02. | Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference | 26 | PR Newswire | |
| UNION CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, Chief... Mehr lesen zu: Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FRESENIUS MEDICAL CARE | 53,09 | -0,95 % | Fresenius Medical Care: Aktienrückkauf beginnt heute |
| FRESENIUS | 94,50 | -0,89 % | Fresenius-Aktie: Übernahmeschlacht mit Asklepios um RHÖN-KLINIKUM doch noch nicht verloren? |
| RHOEN-KLINIKUM | 16,25 | -0,25 % | Commerzbank belässt Rhön-Klinikum auf 'Buy' - Ziel 20,50 Euro |
| DRAEGERWERK | 96,35 | -1,01 % | DGAP-DD: Drägerwerk AG & Co. KGaA (deutsch) |
| CARL ZEISS MEDITEC | 24,50 | +0,45 % | 19. Mai Vintage: Carl-Zeiss, Buick, Post, GNU |
